What is the price-to-earnings ratio of Hybrigenics?
The price-earnings ratio of Hybrigenics is currently -936.81.
Hybrigenics P/E 2024
Hybrigenics P/E
-936.81
Hybrigenics Dividend yield
Ticker
ALHYG.PA
ISIN
FR0004153930
WKN
A0M9ZU
As of May 26, 2024, Hybrigenics's P/E ratio was -936.81, a 623.29% change from the -129.52 P/E ratio recorded in the previous year.
The Hybrigenics P/E history
Hybrigenics Aktienanalyse
What does Hybrigenics do?
Hybrigenics SA is a French company that was founded in 1997 to develop innovative technologies for the discovery and development of new drugs. The company specializes in the identification of proteins responsible for the development of cancer and other diseases, as well as the development of therapies for these diseases. It is headquartered in Paris and has branches in the United States and Japan. Hybrigenics has become a leading provider of protein research technologies since its founding, employing approximately 50 employees including scientists, engineers, and technicians. The company's business model is based on developing innovative technologies for drug discovery and development. It conducts research and development in the field of protein research, particularly protein interaction analysis. The company aims to better understand the mechanism of action of proteins involved in disease development in order to develop targeted therapies. Hybrigenics collaborates closely with its customers to develop tailored solutions for their specific research needs. It provides a range of products and services including proteomic services, screening tools, data analysis software, and platform technologies. The company is divided into different divisions, including proteomic services, screening tools, data analysis software, and platform technologies. Some of the key divisions include proteomic services, which offer customers proteomic services based on decades of experience in protein research and analysis. These services allow customers to identify new proteins involved in specific diseases and also provide protein interaction analysis services to better understand the mechanism of action of disease proteins. Hybrigenics offers screening tools that allow customers to quickly and easily investigate and compare different proteins. These tools are particularly useful for identifying proteins that can serve as indicators for specific diseases. The company also offers data analysis software that enables customers to quickly and accurately evaluate the results of their protein research. This software uses algorithms and artificial intelligence to analyze data and identify patterns. Hybrigenics has also developed a range of platform technologies to help customers optimize their protein research. These technologies include the yeast two-hybrid assay, which can be used to study protein interactions, as well as various technologies for protein expression and purification. Hybrigenics offers a variety of products tailored to its different divisions. Some of the key products include the PIII-Toolbox, a comprehensive platform technology for protein research that allows for fast and efficient identification of protein-protein interactions, HybriScreen Plus, a screening tool that helps customers quickly and easily investigate and compare different proteins, and the yeast two-hybrid assay, a platform technology for studying protein interactions to better understand the mechanism of action of disease proteins. Hybrigenics ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Hybrigenics's P/E Ratio
The Price to Earnings (P/E) Ratio of Hybrigenics is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Hybrigenics's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Hybrigenics is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Hybrigenics’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Hybrigenics Stock
How has the price-earnings ratio of Hybrigenics changed compared to last year?
The price-to-earnings ratio of Hybrigenics has increased by 623.29% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Hybrigenics high compared to other companies?
Yes, the price-to-earnings ratio of Hybrigenics is high compared to other companies.
How does an increase in the price-earnings ratio of Hybrigenics affect the company?
An increase in the price-earnings ratio of Hybrigenics would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Hybrigenics affect the company?
A decrease in the price-earnings ratio of Hybrigenics would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Hybrigenics?
Some factors that influence the price-earnings ratio of Hybrigenics are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Hybrigenics pay?
Over the past 12 months, Hybrigenics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Hybrigenics is expected to pay a dividend of 0 EUR.
What is the dividend yield of Hybrigenics?
The current dividend yield of Hybrigenics is .
When does Hybrigenics pay dividends?
Hybrigenics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Hybrigenics?
Hybrigenics paid dividends every year for the past 0 years.
What is the dividend of Hybrigenics?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Hybrigenics located?
Hybrigenics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Hybrigenics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Hybrigenics from 5/26/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 5/26/2024.
When did Hybrigenics pay the last dividend?
The last dividend was paid out on 5/26/2024.
What was the dividend of Hybrigenics in the year 2023?
In the year 2023, Hybrigenics distributed 0 EUR as dividends.
In which currency does Hybrigenics pay out the dividend?
The dividends of Hybrigenics are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Hybrigenics stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Hybrigenics
Our stock analysis for Hybrigenics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hybrigenics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
